SCIESCOPUSQ1
Blood Advances
ELSEVIER, United States
Blood Advances is an academic journal published by ELSEVIER (United States). Identifiers: ISSN 2473-9529, eISSN 2473-9537. Indexed in SCIE, SCOPUS. Metrics: JIF 7.1, CiteScore 11.7, SJR 2.901, SNIP 1.66. Subject areas: HEMATOLOGY. tlooto lists 6,938 papers from this journal.
CiteScore
11.70
Scopus citation metric
SJR
2.901
SCImago rank
SNIP
1.66
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2473-9529
- eISSN
- 2473-9537
- Abbreviation
- BLOOD ADV
- Publisher
- ELSEVIER
- Country
- United States
Web of Science categories
SCIEHEMATOLOGY
Scopus ASJC categories
2720 Hematology
Keywords
Hematology
Papers in this journal
Recent papers
- Rules, risks, and reality: rethinking gene therapy eligibility
2026 · 1 citations
- Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM
2026
- Sirolimus for Refractory/relapsed Warm Autoimmune Hemolytic Anemia and Evans' syndrome: A Prospective Study.
2026
- Rapid molecular response kinetics to anti-PD-1–based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial
2026
- Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study
2026
Most cited papers
- Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma
2025 · 5,743 citations
- American Society of Hematology 2019 guidelines for immune thrombocytopenia.
2019 · 1,154 citations
- American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.
2020 · 1,100 citations
- Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
2019 · 966 citations
- American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.
2021 · 704 citations